|
Avenue Therapeutics, Inc.
Ticker Symbol: ATXI CUSIP: 05360L304 Previous CUSIP: 05360L106 Exchange: NCM
Company's Online Profile
BUSINESS: Avenue Therapeutics, Inc. is a New York-based, specialty pharmaceutical company focused on the development and commercialization of an intravenous formulation of tramadol HCl for the management of moderate to moderately severe postoperative pain.
|
IPO - 6/27/2017 - 5.50 Million Shares @ $6.00/share.
Link to IPO Prospectus
Micro Cap Stock -
Market Value $ Million
Click for current ATXI price quote from the NASDAQ
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL 33154 |
| Main Phone Number |
781-652-4500 |
| Fax Number |
Not Available |
| Investor Contact (CEO)
Jaclyn Jaffe
|
781-652-4500
|
| CEO - Alexandra MacLean |
CFO - David Jin |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
